Tidal Investments LLC Buys 6,755 Shares of Humana Inc. (NYSE:HUM)

Tidal Investments LLC boosted its stake in shares of Humana Inc. (NYSE:HUM) by 38.4% in the third quarter, Holdings Channel reports. The institutional investor owned 24,357 shares of the insurance provider’s stock after purchasing an additional 6,755 shares during the period. Tidal Investments LLC’s holdings in Humana were worth $7,715,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV lifted its stake in shares of Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after buying an additional 61 shares in the last quarter. CarsonAllaria Wealth Management Ltd. lifted its position in Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after acquiring an additional 39 shares in the last quarter. Atwood & Palmer Inc. purchased a new stake in Humana during the 3rd quarter valued at $29,000. Ashton Thomas Securities LLC purchased a new position in shares of Humana in the third quarter worth $31,000. Finally, Your Advocates Ltd. LLP lifted its holdings in shares of Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Analysts Set New Price Targets

HUM has been the subject of a number of recent analyst reports. KeyCorp began coverage on Humana in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. Stephens restated an “equal weight” rating and issued a $250.00 target price on shares of Humana in a report on Wednesday, October 9th. Jefferies Financial Group lowered shares of Humana from a “buy” rating to a “hold” rating and decreased their target price for the company from $519.00 to $253.00 in a research note on Monday, October 7th. Piper Sandler lowered Humana from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $392.00 to $274.00 in a report on Thursday, October 3rd. Finally, Royal Bank of Canada reduced their price objective on Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Twenty analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $304.15.

Humana Stock Down 1.9 %

Shares of HUM stock opened at $272.78 on Friday. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $488.89. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The company’s fifty day simple moving average is $273.45 and its two-hundred day simple moving average is $325.22. The stock has a market cap of $32.85 billion, a P/E ratio of 24.16, a PEG ratio of 2.15 and a beta of 0.53.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Analysts predict that Humana Inc. will post 16.14 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.30%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s payout ratio is 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.